|
Quotes & Info
|
| ACRX > SEC Filings for ACRX > Form 8-K on 31-Aug-2012 | All Recent SEC Filings |
31-Aug-2012
Other Events, Financial Statements and Exhibits
AcelRx Pharmaceuticals, Inc. (the "Company") is filing this Current Report on Form 8-K to provide a copy of the legal opinion of Cooley LLP relating to the legality of the shares of the Company's Common Stock to be offered and sold pursuant the Company's Registration Statement on Form S-3 (File No. 333-183237) filed with the Securities and Exchange Commission on August 10, 2012 and the related prospectus supplement filed with the Securities and Exchange Commission on August 31, 2012.
(d) Exhibits.
5.1 Opinion of Cooley LLP.
|
|